How I founded Britain's most respected removals firm

'Doing removals defines you for the rest of your working life'

RVMD Sep 2024 26.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

2.5500

0.0000

(0.00%)

At close: 09:30AM EDT

Loading interactive chart…

Simply Wall St.
Shareholders Will Most Likely Find Revolution Medicines, Inc.'s (NASDAQ:RVMD) CEO Compensation Acceptable
Key Insights Revolution Medicines will host its Annual General Meeting on 20th of June Total pay for CEO Mark Goldsmith...
GlobeNewswire
Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
REDWOOD CITY, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company’s chief executive officer and chairman, will be a featured speaker in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference. Details of the company’s participation are as follows: Goldman Sachs 45th Annual Gl
GuruFocus.com
Revolution Medicines Reports Q1 2024 Financial Results: Challenges and Strategic Advances in ...
Insights into RVMD's Financial Health and Future Directions